PUBLIC COMPANY
save$ELDNEledon Pharmaceuticals, Inc.
$ELDNIrvine, CA, USupdated 3mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Phase 3 Randomized Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation
- phase2Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
- phase2Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
- phase2Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
- phase2Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)
🐶 Hiring Signal
News
- Caspian launches with $50M, Lilly support to advance disease-modifying diabetes betKura Oncology has spun out Caspian around KO-7246, which seeks to increase the number and activity of beta cells in the pancreas, in turn boosting insulin production in patients with diabetes.biospace · 22d ago
- Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceAfter the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot in the landscape wi…biospace · 2mo ago
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that